Hepatitis

Hepatitis is inflammation of the liver tissue. Some people or animals with hepatitis have no symptoms, whereas others develop yellow discoloration of the skin and whites of the eyes (jaundice), poor appetite, vomiting, tiredness, abdominal pain, and diarrhea. Hepatitis is acute if it resolves within six months, and chronic if it lasts longer than six months. Acute hepatitis can resolve on its own, progress to chronic hepatitis, or (rarely) result in acute liver failure. Chronic hepatitis may progress to scarring of the liver (cirrhosis), liver failure, and liver cancer.Hepatitis is most commonly caused by the viruses hepatitis A, B, C, …

Wikipedia

Publications

CIHI: Canadian Institute for Health Information · 28 March 2024 English

This report summarizes information about prescription drug data in Canada (assets, needs, gaps, limitations and opportunities) by jurisdiction.

Erythropoietin Program • Growth Hormone Drug Program • Hepatitis Program • Home Oxygen Program • Institutional


Newfoundland & Labrador Department of Health and Community Services · 12 March 2024 English

• combined use of more than one biologic DMARD will not be reimbursed) Claim notes: • Must be prescribed by a rheumatologist or internist • Approvals will be for a …

treatment-experienced* adult patients with chronic hepatitis C infection: Approval Period Genotype 1, 2, 3 expertise in the treatment of hepatitis C infection). • Laboratory confirmed hepatitis C genotype 1, 2, 3, 4 request form: https://www.gov.nl.ca/hcs/files/Hepatitis-C-Treatment-Request-.pdf Updated October 2023 2023 https://www.gov.nl.ca/hcs/files/Hepatitis-C-Treatment-Request-.pdf Health and Community Services GLUCAGON TABLET and generics) Chronic Hepatitis B:  For the treatment of hepatitis B. Note: Must be prescribed


CIHI: Canadian Institute for Health Information · 7 March 2024 English

The data content standard defines the data elements and value sets necessary for connected care.

Tetanus • Human papilloma virus infection • Hepatitis A • Shingles • Tuberculosis • COVID-19 1: Draft Varicella-zoster live attenuated vaccine • HA hepatitis A regular strength unspecified • Var varicella


CADTH: Canadian Agency for Drugs and Technologies in Health · 7 March 2024 English

Clinical experts are a critical part of the review team and are involved in all phases of the 297 review process (e.g., providing guidance on the development of the review …

therapies; GPCR = G-protein-coupled receptor; HBV = Hepatitis B Virus; IFN = interferon; IL = interleukin; IM


OHESI: Ontario HIV Epidemiologic Monitoring Unit, University of Toronto · 5 March 2024 English

By 2022, the total estimated number of individuals dispensed PrEP over the year was 14,650; a 10-fold increase from the estimated 1,451 individuals dispensed PrEP in 2016. [...] The weighting …

is a non-profit network funded by the HIV and Hepatitis C Programs of the Ontario Ministry of Health working treatment, post-exposure prophylaxis (PEP), PrEP and hepatitis B virus treatment. A decision tree was used to treatment of HIV, post-exposure prophylaxis (PEP) and hepatitis B virus treatment. IQVIA leveraged an Indication treatment, post-exposure prophylaxis (PEP), PrEP and hepatitis B virus treatment. However, IQVIA does not collect


OCC: Ontario Chamber of Commerce · 1 March 2024 English

Submission to Provincial Government on Economic Policy

immunizations (e.g., for human papillomavirus, hepatitis B, and conjugated meningitis), including by leveraging


CMA: Canadian Medical Association · 1 March 2024 English

Long-acting injectable antiretroviral therapy for HIV-1 infection in adults Practice | Five things to know about ... [...] CPD Long-acting injectable antiretroviral therapy for HIV-1 infection in adults Sheliza Halani …

RNA < 50 copies/mL).1 Contraindications include hepatitis B co-infection, known resistance to cabotegravir


Newfoundland & Labrador Department of Health and Community Services · 20 February 2024 English

• combined use of more than one biologic DMARD will not be reimbursed) Claim notes: • Must be prescribed by a rheumatologist or internist • Approvals will be for a …

treatment-experienced* adult patients with chronic hepatitis C infection: Approval Period Genotype 1, 2, 3 expertise in the treatment of hepatitis C infection). • Laboratory confirmed hepatitis C genotype 1, 2, 3, 4 request form: https://www.gov.nl.ca/hcs/files/Hepatitis-C-Treatment-Request-.pdf Updated October 2023 2023 https://www.gov.nl.ca/hcs/files/Hepatitis-C-Treatment-Request-.pdf Health and Community Services GLUCAGON TABLET and generics) Chronic Hepatitis B:  For the treatment of hepatitis B. Note: Must be prescribed


INSPQ: Institut national de santé publique du Québec · 13 February 2024 French

Vaccination contre les virus du papillome humain (VPH) en milieu scolaire : Développer des stratégies efficaces pour augmenter les couvertures vaccinales. Ce rapport de recherche porte sur un projet ayant …

des domaines connexes (IRSC projet : Achieving hepatitis C elimination in Canada; addressing the needs


CAMH: Centre for Addiction and Mental Health · 8 February 2024 English

other health agencies and counselling services; harm reduction services for women with HIV/AIDS, hepatitis C Eligibility: Women in Toronto who are ex. [...] 2024 5686t-02/2024 Community-Based Harm Reduction

sex (such as acquiring STIs, including HIV and hepatitis C), reducing the risk of unwanted pregnancy and harm reduction services for women with HIV/AIDS, hepatitis C Eligibility: Women in Toronto who are experiencing


View more